Monday, June 28, 2010

healing



BioMimetic Therapeutics Receives Filing Letter from FDA for Augment(TM) Bone ... - MarketWatch (press release)
BioMimetic Therapeutics Receives Filing Letter from FDA for Augment(TM) Bone ...MarketWatch (press release)rhPDGF-BB is a synthetic form of one of the body's principal agents to stimulate and direct healing and regeneration. The mechanism of action of this ...and more��

Blog Content